{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:40:11Z","timestamp":1787085611405,"version":"build-2736575974"},"reference-count":128,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Bladder cancer (BC) is a common urological cancer, with poor prognosis for advanced\/metastatic stages. Various intensive treatments, including radical cystectomy, chemotherapy, immune therapy, and radiotherapy are commonly used for these patients. However, these treatments often cause complications and adverse events. Therefore, researchers are exploring the efficacy of natural product-based treatment strategies in BC patients. Fucoidan, derived from marine brown algae, is recognized as a multi-functional and safe substrate, and has been reported to have anti-cancer effects in various types of malignancies. Additionally, in vivo and in vitro studies have reported the protective effects of fucoidan against cancer-related cachexia and chemotherapeutic agent-induced adverse events. In this review, we have introduced the anti-cancer effects of fucoidan extracts in BC and highlighted its molecular mechanisms. We have also shown the anti-cancer effects of fucoidan therapy with conventional chemotherapeutic agents and new treatment strategies using fucoidan-based nanoparticles in various malignancies. Moreover, apart from the improvement of anti-cancer effects by fucoidan, its protective effects against cancer-related disorders and cisplatin-induced toxicities have been introduced. However, the available information is insufficient to conclude the clinical usefulness of fucoidan-based treatments in BC patients. Therefore, we have indicated the aspects that need to be considered regarding fucoidan-based treatments and future directions for the treatment of BC.<\/jats:p>","DOI":"10.3390\/cancers12123776","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T09:12:57Z","timestamp":1608023577000},"page":"3776","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Present Status, Limitations and Future Directions of Treatment Strategies Using Fucoidan-Based Therapies in Bladder Cancer"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6272-6657","authenticated-orcid":false,"given":"Yasuyoshi","family":"Miyata","sequence":"first","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9508-0319","authenticated-orcid":false,"given":"Tomohiro","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2841-1998","authenticated-orcid":false,"given":"Kojiro","family":"Ohba","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-5632","authenticated-orcid":false,"given":"Kensuke","family":"Mitsunari","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Mukae","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asato","family":"Otsubo","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.21873\/invivo.11300","article-title":"High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancervia Down-regulation of Human Antigen-R Expression in Never Smokers","volume":"32","author":"Yasuda","year":"2018","journal-title":"In Vivo"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Matsuo, T., Miyata, Y., Yuno, T., Mukae, Y., Otsubo, A., Mitsunari, K., Ohba, K., and Sakai, H. (2020). Molecular Mechanisms of the Anti-Cancer Effects of Isothiocyanates from Cruciferous Vegetables in Bladder Cancer. Molecules, 25.","DOI":"10.3390\/molecules25030575"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rutz, J., Janicova, A., Woidacki, K., Chun, F.K.-H., Blaheta, R.A., and Relja, B. (2020). Curcumin\u2014A Viable Agent for Better Bladder Cancer Treatment. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113761"},{"key":"ref_4","first-page":"333","article-title":"Uroprotective mechanisms of natural products against cyclophosphamide-induced urinary bladder toxicity: A comprehensive review","volume":"19","author":"Sherif","year":"2020","journal-title":"Acta Sci. Pol. Technol. Aliment."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40169-019-0234-9","article-title":"Clinical applications of fucoidan in translational medicine for adjuvant cancer therapy","volume":"8","author":"Hsu","year":"2019","journal-title":"Clin. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/biot.200700054","article-title":"Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds","volume":"3","author":"Kusaykin","year":"2008","journal-title":"Biotechnol. J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ye, J., Chen, D., Ye, Z., Huang, Y., Zhang, N., Lui, E.M.K., Xue, C., and Xiao, M. (2020). Fucoidan Isolated from Saccharina japonica Inhibits LPS-Induced Inflammation in Macrophages via Blocking NF-\u03baB, MAPK and JAK-STAT Pathways. Mar. Drugs, 18.","DOI":"10.3390\/md18060328"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115381","DOI":"10.1016\/j.carbpol.2019.115381","article-title":"Composition, isolation, purification and biological activities of Sargassum fusiforme polysaccharides: A review","volume":"228","author":"Zhang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tox.2009.11.007","article-title":"A 4-week repeated oral dose toxicity study of fucoidan from the Sporophyll of Undaria pinnatifida in Sprague\u2013Dawley rats","volume":"267","author":"Kim","year":"2010","journal-title":"Toxicology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Van Weelden, G., Bobi\u0144ski, M., Ok\u0142a, K., Van Weelden, W.J., Romano, A., and Pijnenborg, J.M.A. (2019). Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms. Mar. Drugs, 17.","DOI":"10.3390\/md17010032"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.7150\/jca.26740","article-title":"Antimetastatic Effect of Fucoidan-Sargassum against Liver Cancer Cell Invadopodia Formation via Targeting Integrin \u03b1V\u03b23 and Mediating \u03b1V\u03b23\/Src\/E2F1 Signaling","volume":"10","author":"Pan","year":"2019","journal-title":"J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chen, L.-M., Tseng, H.-Y., Chen, Y.-A., Al Haq, A.T., Hwang, P.-A., and Hsu, H.-L. (2020). Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression. Cancers, 12.","DOI":"10.3390\/cancers12020421"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ijbiomac.2020.01.256","article-title":"Fucoidan from Laminaria japonica exerts antitumor effects on angiogenesis and micrometastasis in triple-negative breast cancer cells","volume":"149","author":"Hsu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/molecules13081671","article-title":"Fucoidan: Structure and Bioactivity","volume":"13","author":"Li","year":"2008","journal-title":"Molecules"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01233-8","article-title":"The anti-cancer effects of fucoidan: A review of both in vivo and in vitro investigations","volume":"20","author":"Lin","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_16","first-page":"1516","article-title":"Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells","volume":"39","author":"Kim","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2147\/CMAR.S243495","article-title":"Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK\/ERK and PI3K\/Akt Signal Pathways","volume":"12","author":"Duan","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wu, T.C., Hong, Y.H., Tsai, Y.H., Hsieh, S.L., Huang, R.H., Kuo, C.H., and Huang, C.Y. (2020). Degradation of Sargassum crassifolium Fucoidan by Ascorbic Acid and Hydrogen Peroxide, and Compositional, Structural, and In vitro Anti-Lung Cancer Analyses of the Degradation Products. Mar. Drugs, 18.","DOI":"10.3390\/md18060334"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopha.2017.08.013","article-title":"Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K\/AKT\/GSK3\u03b2 pathway in vivo and in vitro","volume":"94","author":"Xue","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ijbiomac.2019.07.043","article-title":"In vitro induction of endoplasmic reticulum stress in human cervical adenocarcinoma HeLa cells by fucoidan","volume":"137","author":"Niyonizigiye","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gupta, D., Silva, M., Radziun, K., Martinez, D.C., Hill, C.J., Marshall, J., Hearnden, V., Puertas-Mej\u00eda, M.A., and Reilly, G.C. (2020). Fucoidan Inhibition of Osteosarcoma Cells is Species and Molecular Weight Dependent. Mar. Drugs, 18.","DOI":"10.3390\/md18020104"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.canep.2010.03.001","article-title":"Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4-hydroxybutyl) nitrosamine-induced bladder cancer","volume":"34","author":"Sagara","year":"2010","journal-title":"Cancer Epidemiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Matsuo, T., Miyata, Y., Asai, A., Sagara, Y., Furusato, B., Fukuoka, J., and Sakai, H. (2017). Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171091"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wu, P., Meng, X., Zheng, H.-D., Zeng, Q., Chen, T., Wang, W., Zhang, X., and Su, J. (2018). Kaempferol Attenuates ROS-Induced Hemolysis and the Molecular Mechanism of Its Induction of Apoptosis on Bladder Cancer. Molecules, 23.","DOI":"10.3390\/molecules23102592"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ramchandani, S., Naz, I., Lee, J.H., Khan, R.A., and Ahn, K.S. (2020). An Overview of the Potential Antineoplastic Effects of Casticin. Molecules, 25.","DOI":"10.3390\/molecules25061287"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fct.2013.12.009","article-title":"AKT signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells","volume":"64","author":"Cho","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.3390\/molecules19055981","article-title":"Fucoidan Inhibits the Proliferation of Human Urinary Bladder Cancer T24 Cells by Blocking Cell Cycle Progression and Inducing Apoptosis","volume":"19","author":"Park","year":"2014","journal-title":"Molecules"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.3390\/md13074436","article-title":"Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1\/VEGF Signaling under Hypoxia","volume":"13","author":"Chen","year":"2015","journal-title":"Mar. Drugs"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bjp.2015.03.011","article-title":"Fucoidan Induces G1 Arrest of the Cell Cycle in EJ Human Bladder Cancer Cells Trough Down-regulation of pRB Phosphorylation","volume":"25","author":"Park","year":"2015","journal-title":"Rev. Bras. Farmacogn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ddr.21367","article-title":"Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K\/Akt Signaling Pathway","volume":"78","author":"Han","year":"2017","journal-title":"Drug Dev. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10616-005-3761-8","article-title":"Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniaekylin Inhibit Invasion and Angiogenesis of Tumor Cells","volume":"47","author":"Ye","year":"2005","journal-title":"Cytotechnology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"115034","DOI":"10.1016\/j.carbpol.2019.115034","article-title":"Fucoidan from FucusVesiculosus Inhibits New Blood Vessel Formation and Breast Tumor Growth In vivo","volume":"223","author":"Oliveira","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01724-6","article-title":"Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas","volume":"39","author":"Mudassar","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2020.07.041","article-title":"Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer","volume":"492","author":"Shah","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Torrisi, F., Vicario, N., Spitale, F.M., Cammarata, F.P., Minafra, L., Salvatorelli, L., Russo, G., Cuttone, G., Valable, S., and Gulino, R. (2020). The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance. Cancers, 12.","DOI":"10.3390\/cancers12102860"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4161\/cc.9.4.10611","article-title":"Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase","volume":"9","author":"Paternot","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00432-017-2524-1","article-title":"Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade","volume":"144","author":"Asai","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_38","first-page":"591","article-title":"NCCN Guidelines Updates: Management of Muscle-Invasive Bladder Cancer","volume":"17","author":"Flaig","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_39","first-page":"31","article-title":"Matrix metalloproteinases and bladder cancer","volume":"48","author":"Kanayama","year":"2001","journal-title":"J. Med. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/iju.12431","article-title":"Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini-review","volume":"21","author":"Wieczorek","year":"2014","journal-title":"Int. J. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.21873\/anticanres.13348","article-title":"The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer","volume":"39","author":"Nakamura","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_42","first-page":"3158","article-title":"High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma","volume":"7","author":"Ohba","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.trsl.2014.06.010","article-title":"Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: A correlation with smoking intensity","volume":"164","author":"Miyata","year":"2014","journal-title":"Transl. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.21873\/anticanres.14351","article-title":"Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9: A Review of Their Role in Breast Cancer Risk","volume":"40","author":"Dofara","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_45","first-page":"1183","article-title":"Fucoidan-Vitamin C complex suppresses tumor invasion through the basement membrane, with scarce injuries to normal or tumor cells, via decreases in oxidative stress and matrix metalloproteinases","volume":"35","author":"Nagai","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lee, H., Kim, J.S., and Kim, E. (2012). Fucoidan from seaweed Fucusvesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050624"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.urology.2004.11.016","article-title":"Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma","volume":"65","author":"Seargent","year":"2005","journal-title":"Urology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.eururo.2006.12.028","article-title":"Expression of Matrix Metalloproteinase-10 in Renal Cell Carcinoma and Its Prognostic Role","volume":"52","author":"Miyata","year":"2007","journal-title":"Eur. Urol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3892\/ol_00000073","article-title":"Expression of matrix metalloproteinase-10 in non-metastatic prostate cancer: Correlation with an imbalance in cell proliferation and apoptosis","volume":"1","author":"Maruta","year":"2010","journal-title":"Oncol. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.21873\/invivo.11345","article-title":"Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer","volume":"32","author":"Liao","year":"2018","journal-title":"In Vivo"},{"key":"ref_51","first-page":"27","article-title":"Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer","volume":"1","author":"Sagara","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Miyata, Y., Matsuo, T., Sagara, Y., Ohba, K., Ohyama, K., and Sakai, H. (2017). A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102214"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/ars.2017.7216","article-title":"NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism","volume":"28","author":"Xiao","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS Function in Redox Signaling and Oxidative Stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Chen, Y.-C., Wang, P.-Y., Huang, B.-M., Chen, Y.-J., Lee, W.C., and Chen, Y.-C. (2020). 16-Hydroxycleroda-3,13-dien-15,16-olide Induces Apoptosis in Human Bladder Cancer Cells through Cell Cycle Arrest, Mitochondria ROS Overproduction, and Inactivation of EGFR-Related Signalling Pathways. Molecules, 25.","DOI":"10.3390\/molecules25173958"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s12094-020-02330-w","article-title":"Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics","volume":"22","author":"Liu","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Witjes, J.A., Bruins, H.M., Cathomas, R., Comp\u00e9rat, E.M., Cowan, N.C., Gakis, G., Hern\u00e1ndez, V., Linares Espin\u00f3s, E., Lorch, A., and Neuzillet, Y. (2020). European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur. Urol., in press.","DOI":"10.1016\/j.eururo.2020.03.055"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1517\/13543784.2015.1109626","article-title":"Docetaxel for the treatment of bladder cancer","volume":"24","author":"Albany","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_60","first-page":"1629","article-title":"Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy","volume":"38","author":"Miyata","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Blaszczak, W., Lach, M.S., Barczak, W., and Suchorska, W.M. (2018). Fucoidan Exerts Anticancer Effects Against Head and Neck Squamous Cell Carcinoma In Vitro. Molecules, 23.","DOI":"10.3390\/molecules23123302"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2174\/1389201018666171115115112","article-title":"Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines","volume":"18","author":"Abudabbus","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2018.05.006","article-title":"Fucoidan upregulates TLR4\/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells","volume":"432","author":"Hsu","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/md11010081","article-title":"Fucoidan Extract Enhances the Anti-Cancer Activity of Chemotherapeutic Agents in MDA-MB-231 and MCF-7 Breast Cancer Cells","volume":"11","author":"Zhang","year":"2013","journal-title":"Mar. Drugs"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1534735416680744","article-title":"Preclinical Evaluation of Safety of Fucoidan Extracts from Undaria pinnatifida and Fucusvesiculosus for Use in Cancer Treatment","volume":"16","author":"Mathew","year":"2017","journal-title":"Integr. Cancer Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1534735417740631","article-title":"Evaluation Fucoidan Extracts from Undaria pinnatifida and Fucusvesiculosus in Combination with Anticancer Drugs in Human Cancer Orthotopic Mouse Models","volume":"17","author":"Burney","year":"2018","journal-title":"Integr. Cancer Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1271\/bbb.120631","article-title":"Induction of Apoptosis by Low-Molecular-Weight Fucoidan through Calcium- and Caspase-Dependent Mitochondrial Pathways in MDA-MB-231 Breast Cancer Cells","volume":"77","author":"Zhang","year":"2013","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Hwang, P.-A., Lin, X.-Z., Kuo, K.-L., and Hsu, F.-Y. (2017). Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells. Materials, 10.","DOI":"10.3390\/ma10030291"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Choi, D.G., Venkatesan, J., and Shim, M.S. (2019). Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan\u2013Fucoidan Nanoparticles. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133220"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"116311","DOI":"10.1016\/j.carbpol.2020.116311","article-title":"Review on marine carbohydrate-based gold nanoparticles represented by alginate and chitosan for biomedical application","volume":"244","author":"Chen","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijbiomac.2020.04.233","article-title":"Mucoadhesive and pH responsive fucoidan-chitosan nanoparticles for the oral delivery of methotrexate","volume":"158","author":"Coutinho","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2217\/nnm-2018-0004","article-title":"Gemcitabine delivered by fucoidan\/chitosan nanoparticles presents increased toxicity over human breast cancer cells","volume":"13","author":"Oliveira","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lai, Y.-H., Chiang, C., Hsu, C.-H., Cheng, H.-W., and Chen, S.-Y. (2020). Development and Characterization of a Fucoidan-Based Drug Delivery System by Using Hydrophilic Anticancer Polysaccharides to Simultaneously Deliver Hydrophobic Anticancer Drugs. Biomolecules, 10.","DOI":"10.3390\/biom10070970"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Chen, M.-L., Lai, C.-J., Lin, Y.-N., Huang, C.-M., and Lin, Y.-H. (2020). Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects. J. Mater. Chem. B.","DOI":"10.1039\/D0TB01733G"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00280-012-1938-3","article-title":"Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: A retrospective analysis","volume":"70","author":"Miyata","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12032-015-0683-y","article-title":"Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer","volume":"32","author":"Miyata","year":"2015","journal-title":"Med Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2174\/1567201810666131124140259","article-title":"Investigation of fucoidan-oleic acid conjugate for delivery of curcumin and paclitaxel","volume":"16","author":"Phan","year":"2013","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2174\/1871520617666171121125845","article-title":"A Comparison of Fucoidan Conjugated to Paclitaxel and Curcumin for the Dual Delivery of Cancer Therapeutic Agents","volume":"18","author":"Phan","year":"2019","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Miyata, Y., Matsuo, T., Araki, K., Nakamura, Y., Sagara, Y., Ohba, K., and Sakai, H. (2018). Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer. Medicines, 5.","DOI":"10.3390\/medicines5030087"},{"key":"ref_80","first-page":"425","article-title":"(-)-Epigallocatechin 3 gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway","volume":"42","author":"Sun","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Piwowarczyk, L., Stawny, M., Mlynarczyk, D.T., Muszalska, I., Goslinski, T., and Jeli\u0144ska, A. (2020). Role of Curcumin and (\u2212)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review. Cancers, 12.","DOI":"10.3390\/cancers12071801"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3892\/ol.2011.254","article-title":"Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer","volume":"2","author":"Ikeguchi","year":"2011","journal-title":"Oncol. Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","article-title":"Cancer Cachexia: More Than Skeletal Muscle Wasting","volume":"4","author":"Schmidt","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/601434","article-title":"Cancer Cachexia: Mechanisms and Clinical Implications","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"51608","DOI":"10.18632\/oncotarget.9958","article-title":"Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: Rationale for the MENAC (Multimodal\u2014Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial","volume":"8","author":"Solheim","year":"2018","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Cruz, B.L.G., Oliveira, A.G., Viana, L.R., Lopes-Aguiar, L., Canevarolo, R., Colombera, M.C., Valentim, R.R., Garcia-F\u00f3ssa, F., De Sousa, L.M., and Castelucci, B.G. (2020). Leucine-Rich Diet Modulates the Metabolomic and Proteomic Profile of Skeletal Muscle during Cancer Cachexia. Cancers, 12.","DOI":"10.3390\/cancers12071880"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Fukushima, H., Takemura, K., Suzuki, H., and Koga, F. (2018). Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201808.0077.v1"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jcsm.12279","article-title":"Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer","volume":"9","author":"Mayr","year":"2018","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"ref_91","first-page":"372","article-title":"Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder","volume":"37","author":"Vartolomei","year":"2019","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Chen, M.-C., Chen, Y.-L., Lee, C.-F., Hung, C.-H., and Chou, T.-C. (2015). Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143594"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Miyake, M., Hori, S., Itami, Y., Oda, Y., Owari, T., Fujii, T., Ohnishi, S., Morizawa, Y., Gotoh, D., and Nakai, Y. (2020). Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model. Cancers, 12.","DOI":"10.3390\/cancers12071942"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1016\/j.fct.2012.09.020","article-title":"Low molecular weight fucoidan ameliorating the chronic cisplatin-induced delayed gastrointestinal motility in rats","volume":"50","author":"Song","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.21873\/anticanres.13744","article-title":"Protective Role of Fucoidan on Cisplatin-mediated ER Stress in Renal Proximal Tubule Epithelial Cells","volume":"39","author":"Kim","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.carbpol.2013.02.047","article-title":"Fucoidan from New Zealand Undaria pinnatifida: Monthly variations and determination of antioxidant activities","volume":"95","author":"Mak","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnut.2014.00009","article-title":"Anti-Proliferation Potential and Content of Fucoidan Extracted from Sporophyll of New Zealand Undaria pinnatifida","volume":"1","author":"Mak","year":"2014","journal-title":"Front. Nutr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1134\/S1063074016040106","article-title":"Seasonal variations in the fucoidan content of brown algae from Peter the Great Bay, Sea of Japan","volume":"42","author":"Skriptsova","year":"2016","journal-title":"Russ. J. Mar. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/md13031084","article-title":"Fucoidan from Macrocystispyrifera has powerful immune-modulatory effects compared to three other fucoidans","volume":"13","author":"Zhang","year":"2015","journal-title":"Mar. Drugs"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijbiomac.2013.06.030","article-title":"Brown seaweed fucoidan: Biological activity and apoptosis, growth signaling mechanism in cancer","volume":"60","author":"Kalimuthu","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/glycob\/cwm014","article-title":"A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds","volume":"17","author":"Cumashi","year":"2007","journal-title":"Glycobiology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1271\/bbb.90705","article-title":"Development of a Fucoidan-Specific Antibody and Measurement of Fucoidan in Serum and Urine by Sandwich ELISA","volume":"74","author":"Tokita","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1358\/mf.2005.27.10.948919","article-title":"A quantitative method to detect fucoidan in human plasma using a novel antibody","volume":"27","author":"Irhimeh","year":"2005","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_104","first-page":"695","article-title":"Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells","volume":"15","author":"Matsubara","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"ref_105","unstructured":"Nguyen, M., Smith, S.T., Lam, M., Liow, E., Davies, A., Prenen, H., and Segelov, E. (2020). An update on the use of immunotherapy in patients with colorectal cancer. Expert Rev. Gastroenterol. Hepatol., 1\u201314."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Roviello, G., Catalano, M., Nobili, S., Santi, R., Mini, E., and Nesi, G. (2020). Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217935"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"102115","DOI":"10.1016\/j.ctrv.2020.102115","article-title":"Sarcomas: Immune biomarker expression and checkpoint inhibitor trials","volume":"91","author":"Zhu","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.intimp.2007.10.017","article-title":"Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection","volume":"8","author":"Hayashi","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"ref_109","first-page":"1","article-title":"Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_110","first-page":"6041","article-title":"Fucoidans Stimulate Immune Reaction and Suppress Cancer Growth","volume":"37","author":"Vetvicka","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"18627","DOI":"10.1073\/pnas.2004421117","article-title":"Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-\u03b3 signaling","volume":"117","author":"Antonelli","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Das, S., Camphausen, K., and Shankavaram, U. (2020). Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies. Cancers, 12.","DOI":"10.3390\/cancers12092476"},{"key":"ref_113","first-page":"1331","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first-line chemotherapy","volume":"43","author":"Vallo","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e12830","DOI":"10.1111\/sji.12830","article-title":"Tumour-associated B cells in urothelial urinary bladder cancer","volume":"91","author":"Zirakhzadeh","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Patel, V., Oh, W.K., and Galsky, M. (2020). Treatment of muscle-invasive and advanced bladder cancer in 2020. CA A Cancer J. Clin.","DOI":"10.3322\/caac.21631"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajco.13312","article-title":"Immunotherapy for urothelial carcinoma: Metastatic disease and beyond","volume":"16","author":"Poon","year":"2020","journal-title":"Asia-Pacific J. Clin. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1600106","DOI":"10.1002\/advs.201600106","article-title":"Chemophototherapy: An Emerging Treatment Option for Solid Tumors","volume":"4","author":"Luo","year":"2017","journal-title":"Adv. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.2147\/IJN.S269321","article-title":"Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles","volume":"15","author":"Hou","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Sundaram, P., and Abrahamse, H. (2020). Phototherapy Combined with Carbon Nanomaterials (1D and 2D) and their Applications in Cancer Therapy. Materials, 13.","DOI":"10.3390\/ma13214830"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Lu, K.-Y., Jheng, P.-R., Lu, L.-S., Rethi, L., Mi, F.-L., and Chuang, E.-Y. (2020). Enhanced anticancer effect of ROS-boosted photothermal therapy by using fucoidan-coated polypyrrole nanoparticles. Int. J. Biol. Macromol.","DOI":"10.1016\/j.ijbiomac.2020.10.091"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.trsl.2016.04.002","article-title":"Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer","volume":"175","author":"Mitsunari","year":"2016","journal-title":"Transl. Res."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Ismail, T., Kim, Y., Lee, H., Lee, D.-S., and Lee, H.-S. (2019). Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184407"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Ntellas, P., Mavroeidis, L., Gkoura, S., Gazouli, I., Amylidi, A.-L., Papadaki, A., Zarkavelis, G., Mauri, D., Karpathiou, G., and Kolettas, E. (2020). Old Player-New Tricks: Non Angiogenic Effects of the VEGF\/VEGFR Pathway in Cancer. Cancers, 12.","DOI":"10.3390\/cancers12113145"},{"key":"ref_125","first-page":"81","article-title":"Activation of NK cells in male cancer survivors by fucoidan extracted from Cladosiphonokamuranus","volume":"12","author":"Nagamine","year":"2020","journal-title":"Mol. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Gueven, N., Spring, K.J., Holmes, S., Ahuja, K.D.K., Eri, R., Park, A.Y., and Fitton, J.H. (2020). Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study. Mar. Drugs, 18.","DOI":"10.3390\/md18030143"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.atherosclerosis.2019.06.425","article-title":"99mTc-Fucoidn as diagnostic agent for P-selectin imaging: First-in-human evaluation (phase I)","volume":"287","author":"Zheng","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-1885-y","article-title":"Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: Possible JAK-STAT3 pathway","volume":"17","author":"Rui","year":"2017","journal-title":"BMC Complement. Altern. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3776\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:16Z","timestamp":1760179516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":128,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["cancers12123776"],"URL":"https:\/\/doi.org\/10.3390\/cancers12123776","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}